HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → (3,5-Dibromo-4-hydroxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Lithium Bromide | HCID 82050 | — |
| Reactant | HCID 44608067 | HCID 44608067 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | (3,5-Dibromo-4-hydroxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone | HCID 44608068 | 86% |
Reaction Steps
In a 5 ml flask, (3,5-dibromo-4-methoxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone (30 mg, 0.061 mmol) was dissolved in N,N-dimethyl formamide (0.3 ml), and then lithium bromide (10 mg, 0.12 mmol) and piperazine (7.8 mg, 0.091 mmol) were added thereto. After stirring for 1 hour, the solvent was removed by evaporation under reduced pressure. The residue was neutralized with water and 1N hydrochloric acid. The resulting solid was filtered to obtain the target compound 22-2 as white solid (25 mg, 86%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08394792B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-83b42c513f2a422c9f1b9d2161306eef |
| Source note | uspto-grants-2013_03 |